drugset / Trial / NCT07368972
Study of DISC-0974-201 in Participants With IBD and Anemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.
Timeline
- Start
- 2026-02-20
- Primary completion
- 2026-10
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DISC-0974 | Monoclonal antibody | 60 mg | Subcutaneous |